One year in review
One year in review 2018: gout
L. Punzi1, A. Scanu2, P. Spinella3, P. Galozzi4, F. Oliviero5
- Centre for Gout and Metabolic Bone and Joint Diseases, Rheumatology, SS Giovanni and Paolo, Venice, Italy. punzileonardo@gmail.com
- Rheumatology Unit, Department of Medicine - DIMED, University of Padova, ltaly.
- Clinical Nutrition Unit, Department of Medicine - DIMED, University of Padova, ltaly.
- Rheumatology Unit, Department of Medicine - DIMED, University of Padova, ltaly.
- Rheumatology Unit, Department of Medicine - DIMED, University of Padova, ltaly.
CER11774
2019 Vol.37, N°1
PI 0001, PF 0011
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 30620275 [PubMed]
Received: 24/09/2018
Accepted : 15/10/2018
In Press: 21/12/2018
Published: 18/01/2019
Abstract
Gout is the most common form of inflammatory arthropathy, and is associated with excruciating pain, major impairment of quality of life, and increased risk of comorbidities and mortality. Although gout has somehow been neglected by researchers and clinicians in the past, in more recent times there has been a renewed interest in this disease, which has led to major improvements in its management. This article reviews the new clinical and experimental evidence about gout that emerged in 2017 and in the first half of 2018.
